Garry Nolan

Garry Nolan

Professor in Pathology at Stanford University School of Medicine; pioneer in spatial biology; co-founder of numerous LST & DX companies with successful IPOs/exits

Garry Nolan is Rachford and Carlota A. Harris Professor in Pathology at Stanford University School of Medicine. Garry has published >350 research articles, is the holder of 50 US patents, and has been honored as a top 25 inventor at Stanford. He cloned and characterized key transcription factors in immune regulation, such as NF-KB p65, and was a creator of the 293T retroviral packaging systems used extensively in clinical human gene therapy. Dr. Nolan was a founder of Rigel Inc. (Nasdaq: RIGL), BINA (genomics computational company sold to Roche Dx), Apprise (sold to Roche Sequencing Solutions), and coFounder of Ionpath and of Akoya (Nasdaq: AKYA). Dr. Nolan said: “Humanity’s creativity is exemplified in the goals of the Copernicus Space Corporation. I am thrilled to be a part of this superb merging of technology, biotech, and more that will extend human reach beyond our first planetary home.”